Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway

Neoplasia

Volumn 4, Issue 5, 2002, Pages 400-408

  Wan, Xiaolin ^a   Helman, Lee J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis; Cisplatin; IGF II; p70 S6K; Survival

Indexed keywords

CISPLATIN; MITOGENIC AGENT; RAPAMYCIN; S6 KINASE; SOMATOMEDIN B; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CARRIER PROTEIN; EIF4EBP1 PROTEIN, HUMAN; EIF4EBP1 PROTEIN, MOUSE; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL ACTIVITY; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; ANIMAL; CELL DIVISION; CELL LINE; DRUG ANTAGONISM; DRUG RESISTANCE; ENZYMOLOGY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CISPLATIN; CYTOPROTECTION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MICE; MYOBLASTS; PHOSPHOPROTEINS; PHOSPHORYLATION; RHABDOMYOSARCOMA; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSFECTION; UP-REGULATION;

EID: 0036708503     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900242     Document Type: Article

References (42)

1. Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors
2. The molecular and cellular biology of insulin-like growth factor II
3. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
4. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action
5. Insulin-like growth factors and their binding proteins: Biological actions
6. Expression of insulin-like growth factor-II transcriptions in Wilms' tumour
7. Insulin-like growth factor II-mediated proliferation of human neuroblastoma
8. Involvement of IGF-II in human cancer
9. Insulin-like growth factor overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype
10. 1 checkpoint after γ-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression
11. Heritable formation of pancreatic beta-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
12. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
13. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
14. p70 S6 kinase: An enigma with variations
15. The 70 kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signaling
16. The molecular phosphorylation and activation of p70s6k
17. TOR signaling and control of cell growth
18. Translation control: Connecting mitogens and the ribosome
19. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain
20. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation
21. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase
22. The elF4E-binding proteins 1 and 2 are negative regulators of cell growth
23. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma
24. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors
25. Size control in animal development
26. Animal cell cycles and their control
27. Growth-dependent translation of IGF-II mRNA by a repamycine-sensitive pathway
28. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signaling
29. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells
30. The mRNA 5′ cap-binding protein elF4E and control of cell growth
31. Translational control of the antiapoptotic function of Ras
32. Drugs five years later
33. Cisplatin and DNA Repair in cancer chemotherapy
34. Cisplatin induces a persistent activation of JNK that is related to cell death
35. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard
36. Inhibition of telomerase activity by cisplatin in human testicular cancer cells
37. Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells
38. Ovarian cancer: Part II. Treatment
39. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: Mechanisms and implications